New appetite drug shows promise in overweight women
NCT ID NCT06621017
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 27 times
Summary
This study tested a daily injection called ROSE-010 in 40 overweight and obese women to see if it reduces appetite and food intake. Participants received either the drug or a placebo, and researchers measured how much they ate at lunch and their hunger levels. The goal was to find a safe way to help control eating and support weight management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY/OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medpace Clinical Pharmacology
Cincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.